In this podcast, we will mostly dive into some of the latest but also long-standing industry and regulatory issues in China surrounding the accessibility of innovative healthcare products, their current policy regulation standings, and what are areas where the industry can call for additional improvement actions.  

These actions will not only benefit multinational and domestic healthcare businesses, but also will improve China’s overall healthcare landscape and development quality.